Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Frost & Sullivan Lauds Adcock Ingram's Capability to Innovatively Cater to the Dynamic Needs of Emerging Pharmaceuticals Markets - Unique market models backed by structured strategies have enabled the company to rapidly and robustly expand in emerging markets - Adcock.com / Frost.com
Frost & Sullivan Lauds Adcock Ingram's Capability to Innovatively Cater to the Dynamic Needs of Emerging Pharmaceuticals Markets

 

PRZOOM - /newswire/ - Cape Town, South Africa, 2013/09/16 - Unique market models backed by structured strategies have enabled the company to rapidly and robustly expand in emerging markets - Adcock.com / Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Based on its recent research on the pharmaceuticals and healthcare market, Frost & Sullivan presents Adcock Ingram with the 2013 Emerging Market Innovation Award for reorienting its strategies, services and business models to cater to emerging markets. Adcock Ingram's resolute focus on growth through geographic expansion has contributed to its success within Africa and in international markets.

Specializing in the three main business areas of prescription pharmaceuticals, pharmaceutical over the counter (OTC) and hospital care in emerging markets, Adcock Ingram's success is underpinned by its localisation strategy - establishing a local presence and using local talent to overcome administrative inefficiencies. In India, for instance, the company deploys 1,200 representatives in 29 states and has introduced close to 130 products, which are being aggressively marketed.

"Adcock Ingram understands that a one-size-fits-all strategy is not viable for emerging markets," said Frost & Sullivan Research Analyst Anushree Warrier. "Implementing improvised strategies in tandem with the emerging market's requirements further acts to fortify the company's market acceptance."

"In South Africa, for instance," Warrier continues,"the company has undertaken innovative packaging, where packs of ones and twos are made to be sold at a very affordable price. In India, the company has chosen to prioritise the OTC market with prospects of gradually venturing into medical devices or ancillary healthcare offerings."

Similarly, Adcock Ingram meticulously plans to leverage the demographic profile of target countries, including them as a core to its emerging market strategy. Focusing on countries with similar demographic profiles and disease burdens speeds up market penetration. The company has made inroads in India, begun exporting to South East Asian markets such as Malaysia, and is making an initial foray into Pakistan, Thailand, Indonesia, Mongolia, and Vietnam.

Adcock Ingram has also earned the reputation of sound quality assurance, reliable quality control, and the ability to distribute its products effectively and safely. The company has a strong and effective cold chain and its R&D facility is one of the only four in the world that is pre-qualified to test and release products on behalf of the WHO.

"Pioneering self-reliant distribution facilities that connect regions and customers to its product base, Adcock Ingram has overcome challenges such as communication barriers, lack of infrastructure in transport and distribution facilities, and has continued its diligence in manufacturing, marketing, and distributing its products effectively," observes Warrier.

The backbone of this success is its innovative business model, Broad Based Black Economic Empowerment (B-BBEE) that aims at building a dedicated team trained to cater to more advanced world-class scientific based selling. The program consists of several schemes that support economic employment parity to make employees self-reliant and more dedicated; novel packaging initiatives that are convenient and patient compliant; and collaborative efforts with leading multinational companies.

"Adcock Ingram has let risk-aversion take a back seat in its business models by intelligently identifying, gauging, and deciding whether risks can be sufficiently mitigated," concludes Warrier. "This company has shown tactical superiority, utilising intelligent business models to manufacture and deliver medication across emerging markets, resulting in exemplary growth across emerging markets."

In recognition of its achievements, Adcock Ingram is being recognized with the 2013 Emerging Market Innovation Award in pharmaceuticals and healthcare. Each year, Frost & Sullivan presents this award to the company that that has demonstrated focus on growth through geographic expansion. The award recognizes the company's ability to localize for emerging market requirements, using an inclusive approach, customer service, and unique 'go-to-market' models.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Adcock Ingram
Adcock Ingram (adcock.com) is a leading South African pharmaceutical company. The company provides an extensive portfolio of branded and generic medicines, has a strong presence in over-the-counter market, and is South Africa's largest supplier of hospital and critical care products.

Our Vision is to be recognised as a leading world class branded healthcare company. Our mission is to 'Add Value to Life'.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion | Join Us: Join our community | Subscribe: Newsletter on "the next big thing" | Register: Gain access to visionary innovation

Contact:
Vicki St Quintin - Group Corporate Affairs and Investor Relations Manager
Adcock Ingram
T: +27 11 635 0171 / C: +27824534367
E: Vicki.StQuintin[.]adcock.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Lauds Adcock Ingram's Capability to Innovatively Cater to the Dynamic Needs of Emerging Pharmaceuticals Markets

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan | Adcock Ingram
Contact: Samantha James - Frost.com 
+27-21-680-3574 samantha.james[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today